# Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery

> **NCT01936233** · PHASE3 · UNKNOWN · sponsor: **Fudan University** · enrollment: 112 (estimated)

## Conditions studied

- Hepatocellular Carcinoma
- Recurrence

## Interventions

- **DRUG:** Aspirin
- **DRUG:** Lamivudine

## Key facts

- **NCT ID:** NCT01936233
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-08
- **Primary completion:** 2021-12
- **Final completion:** 2023-12
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2019-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01936233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01936233, "Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT01936233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*